Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Nov 30, 2025 | (Q2)Aug 31, 2025 | (Q1)May 31, 2025 | (FY)Feb 28, 2025 | (Q4)Feb 28, 2025 | (Q3)Nov 30, 2024 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.25%141.8M | 2.69%129.6M | -1.38%121.7M | -29.53%534.9M | -7.45%141.7M | -5.53%143.6M | -4.39%126.2M | -66.92%123.4M | 44.23%759.1M | 618.78%153.1M |
| Operating revenue | -1.25%141.8M | 2.69%129.6M | -1.38%121.7M | -29.53%534.9M | -7.45%141.7M | -5.53%143.6M | -4.39%126.2M | -66.92%123.4M | 44.23%759.1M | 618.78%153.1M |
| Cost of revenue | 1.59%31.9M | -12.23%33M | -5.99%31.4M | -47.84%140M | 27.89%37.6M | -4.85%31.4M | -20.00%37.6M | -82.78%33.4M | 68.07%268.4M | 211.79%29.4M |
| Gross profit | -2.05%109.9M | 9.03%96.6M | 0.33%90.3M | -19.52%394.9M | -15.84%104.1M | -5.71%112.2M | 4.24%88.6M | -49.72%90M | 33.85%490.7M | 159.87%123.7M |
| Operating expense | 5.75%97.4M | -1.40%84.6M | -11.27%88.2M | -14.22%381.8M | -9.21%104.5M | -12.29%92.1M | -37.37%85.8M | -40.83%99.4M | 2.04%445.1M | 299.13%115.1M |
| Selling and administrative expenses | 9.36%65.4M | 3.33%55.9M | -7.64%59.2M | -12.36%255.2M | -4.93%77.2M | -14.57%59.8M | -25.89%54.1M | -35.25%64.1M | 6.05%291.2M | 361.36%81.2M |
| -Selling and marketing expense | 25.21%29.3M | 14.55%24.4M | 20.59%28.7M | -8.17%95.5M | 0.00%27M | -6.40%23.4M | -50.47%21.3M | -47.11%23.8M | 1.36%104M | --27M |
| -General and administrative expense | -0.82%36.1M | -3.96%31.5M | -24.32%30.5M | -14.69%159.7M | -7.38%50.2M | -19.11%36.4M | 9.33%32.8M | -25.37%40.3M | 8.84%187.2M | 163.76%54.2M |
| Research and development costs | 6.09%29.6M | -5.54%25.6M | -18.30%25M | -14.40%108.8M | -20.27%23.2M | -3.79%27.9M | -45.80%27.1M | -43.33%30.6M | -5.29%127.1M | 217.34%29.1M |
| Depreciation amortization depletion | -45.45%2.4M | -32.61%3.1M | -14.89%4M | -33.58%17.8M | -14.58%4.1M | -26.67%4.4M | -67.14%4.6M | -68.67%4.7M | -2.19%26.8M | 109.49%4.8M |
| -Depreciation and amortization | -45.45%2.4M | -32.61%3.1M | -14.89%4M | -33.58%17.8M | -14.58%4.1M | -26.67%4.4M | -67.14%4.6M | -68.67%4.7M | -2.19%26.8M | 109.49%4.8M |
| Operating profit | -37.81%12.5M | 328.57%12M | 122.34%2.1M | -71.27%13.1M | -104.65%-400K | 43.57%20.1M | 105.38%2.8M | -185.45%-9.4M | 165.52%45.6M | -91.84%8.6M |
| Net non-operating interest income (expenses) | -45.00%-2.9M | -7.14%-6M | 0.00%-2M | 12.50%-5.6M | ||||||
| Non-operating interest expense | ---- | ---- | 45.00%2.9M | 7.14%6M | ---- | ---- | ---- | 0.00%2M | -12.50%5.6M | ---- |
| Other net income (expenses) | 291.67%2.3M | -33.33%1.4M | 1,040.00%5.7M | 112.62%1.3M | 99.25%-100K | -113.33%-1.2M | -82.50%2.1M | 102.94%500K | 91.81%-10.3M | 81.98%-13.3M |
| Gain on sale of security | 583.33%2.9M | -29.63%1.9M | 45.00%5.8M | -43.85%13.7M | -19.15%7.6M | -112.00%-600K | -61.43%2.7M | -20.00%4M | 114.04%24.4M | -24.19%9.4M |
| Special income (charges) | 0.00%-600K | 16.67%-500K | 97.14%-100K | 60.26%-12.4M | 65.32%-7.7M | 93.33%-600K | 40.00%-600K | ---3.5M | 88.64%-31.2M | 80.11%-22.2M |
| -Less:Impairment of capital assets | 0.00%600K | -16.67%500K | -97.14%100K | -69.23%9.6M | -77.93%4.9M | -93.33%600K | -40.00%600K | --3.5M | -73.01%31.2M | -80.11%22.2M |
| -Less:Other special charges | ---- | ---- | ---- | --2.8M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -102.55%-3.5M | -101.97%-500K |
| Income before tax | -21.69%14.8M | 173.47%13.4M | 155.06%4.9M | -71.48%8.5M | 37.25%-6.4M | -17.83%18.9M | 112.25%4.9M | -11.25%-8.9M | 114.77%29.8M | -140.48%-10.2M |
| Income tax | -83.33%1.1M | -92.86%100K | -60.53%3M | -29.75%17M | -66.67%1.4M | -56.00%6.6M | -30.00%1.4M | 153.33%7.6M | 76.64%24.2M | 147.06%4.2M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 230.48%13.7M | 167.51%13.3M | 104.59%1.9M | 39.32%-79M | 86.83%-7.4M | 50.00%-10.5M | 53.10%-19.7M | -276.36%-41.4M | 82.27%-130.2M | 88.66%-56.2M |
| Net income continuous operations | 11.38%13.7M | 280.00%13.3M | 111.52%1.9M | -251.79%-8.5M | 45.83%-7.8M | 53.75%12.3M | 108.33%3.5M | -50.00%-16.5M | 102.60%5.6M | -161.28%-14.4M |
| Net income discontinuous operations | --0 | --0 | --0 | 48.09%-70.5M | 100.96%400K | 21.38%-22.8M | ---23.2M | ---24.9M | 73.83%-135.8M | ---41.8M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 230.48%13.7M | 167.51%13.3M | 104.59%1.9M | 39.32%-79M | 86.83%-7.4M | 50.00%-10.5M | 53.10%-19.7M | -276.36%-41.4M | 82.27%-130.2M | 88.66%-56.2M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 230.48%13.7M | 167.51%13.3M | 104.59%1.9M | 39.32%-79M | 86.83%-7.4M | 50.00%-10.5M | 53.10%-19.7M | -276.36%-41.4M | 82.27%-130.2M | 88.66%-56.2M |
| Diluted earnings per share | 200.00%0.02 | 166.67%0.02 | 0 | 40.91%-0.13 | 90.00%-0.01 | 50.00%-0.02 | 57.14%-0.03 | -250.00%-0.07 | 82.68%-0.22 | 88.24%-0.1 |
| Basic earnings per share | 200.00%0.02 | 166.67%0.02 | 0 | 40.91%-0.13 | 90.00%-0.01 | 60.00%-0.02 | 57.14%-0.03 | -250.00%-0.07 | 83.70%-0.22 | 88.24%-0.1 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.